APA (7th ed.) Citation

F, S., M, P., A, C., B, C., S, B., S, L., . . . P, C. (2025). Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study. Transplantation and cellular therapy, 31(4), 240.e1-240.e9. https://doi.org/10.1016/j.jtct.2025.01.888

Chicago Style (17th ed.) Citation

F, Stella, et al. "Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study." Transplantation and Cellular Therapy 31, no. 4 (2025): 240.e1-240.e9. https://doi.org/10.1016/j.jtct.2025.01.888.

MLA (9th ed.) Citation

F, Stella, et al. "Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study." Transplantation and Cellular Therapy, vol. 31, no. 4, 2025, pp. 240.e1-240.e9, https://doi.org/10.1016/j.jtct.2025.01.888.